Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

655.00p
   
  • Change Today:
      38.00p
  • 52 Week High: 682.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 120.54m
  • Volume: 272,546
  • Market Cap: £789.53m
  • RiskGrade: 125
  • Beta: 1.78

Latest ShareCast News

Total Voting Rights

By Sharecast

Date: Friday 02 Jan 2026

OXB ShareCast News

Block Listing Return 02-Jan-2026 ShareCast
Oxford Biomedica acquires US viral vector facility 07-Oct-2025 ShareCast
Oxford Biomedica reiterates outlook as interim l... 23-Sep-2025 ShareCast
RBC Capital Markets raises target price on OXB 26-Aug-2025 ShareCast
Oxford Biomedica raises £60m to bolster US capac... 15-Aug-2025 ShareCast

OXB Regulatory News

Total Voting Rights 02-Jan-2026 07:00 RNS
Block Listing Return 02-Jan-2026 07:00 RNS
Block Listing Return 02-Jan-2026 07:00 RNS
Total Voting Rights 02-Jan-2026 07:00 RNS
PDMR Dealing 08-Dec-2025 15:15 RNS

OXB Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ... 16-Aug-2008 Times
Need to know 10-May-2008 Times
DSG International may be losing its spark 12-Feb-2008 Telegraph
Oxford BioMedica clinches $690m licensing deal f... 29-Mar-2007 The Independent
Oxford Biomedica seals €518m deal with Sanofi ov... 29-Mar-2007 Times

OXB Tips & Analysis

FTSE 100 latest: Oil falls take shares lower 06-Jul-2009 Daily Mail
The Investment Column: Oxford Biomedica 11-Mar-2008 The Independent
Jetion could benefit from Spanish election 11-Mar-2008 Times
The Week Ahead: Kazakh and Tate & Lyle head for ... 10-Mar-2008 The Independent
Market Report: Prudential driven up on Chinese b... 06-Mar-2008 The Independent

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 655.00p
Change Today 38.00p
% Change 6.16 %
52 Week High 682.00
52 Week Low 232.50
Volume 272,546
Shares Issued 120.54m
Market Cap £789.53m
Beta 1.78
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 3
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 02-Jan-2026

Time Volume / Share Price
16:47 1,806 @ 641.88p
16:37 16,462 @ 655.00p
16:35 66,083 @ 655.00p
16:35 229 @ 655.00p
16:35 444 @ 655.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page